ClinConnect ClinConnect Logo
Search / Trial NCT05766579

Comparison Trial Between Elastic-compressive Stockings at 21 Versus 32 mmHg

Launched by IRCCS POLICLINICO S. DONATO · Mar 10, 2023

Trial Information

Current as of November 08, 2025

Recruiting

Keywords

Stockings, Compression Thermoablation Radiofrequency Saphenous Vein

ClinConnect Summary

This clinical trial is comparing two different types of elastic compression stockings, one with a pressure of 21 mmHg and the other with 32 mmHg, to see which one works better after a specific procedure for treating varicose veins called radiofrequency ablation. Varicose veins can cause swelling and pain in the legs, and these stockings are meant to help reduce these issues after surgery. The trial is important because there isn’t enough research on how different levels of compression affect patients after this type of treatment, and many patients find higher compression levels uncomfortable.

To be eligible for this trial, participants must be adults over 18 years old who have been diagnosed with varicose veins and are scheduled to undergo the radiofrequency ablation procedure. However, people with certain conditions, like severe artery disease or obesity, and those who are pregnant cannot participate. If you join the study, you will wear one of the two types of stockings after your procedure, and researchers will monitor how you feel and any side effects you might experience. This could help improve future care for patients after varicose vein surgeries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adult patients (\>18 years) suffering from varicose vein pathology of the lower limbs C2-3 class (varicose veins, edema) according to Clinic, Etiology, Anatomy, Pathophysiology (CEAP) classification, supported by incontinence of the great saphenous vein documented by Echo-Duplex study and candidates for thermal ablation by radiofrequency of the great vein saphenous vein with associated phlebectomy of the ipsilateral thigh and/or leg varices.
  • Exclusion Criteria:
  • Patients who are minors (\< 18 years old) or adults who have not given their consent to participate in the study.
  • Presence of severe obliterating arterial disease of the lower limbs (ABI \<0.5)
  • Obesity (BMI \>30)
  • * Varicose pathology of the lower limbs in C4-C6 class according to Clinic, Etiology, Anatomy, Pathophysiology (CEAP) classification (presence of:
  • lipodermatosclerosis/eczema and/or ulcers in progress and/or previous ulcers in the affected lower limb).
  • Pregnancy.

About Irccs Policlinico S. Donato

IRCCS Policlinico S. Donato is a leading Italian research hospital and clinical trial sponsor dedicated to advancing medical science through innovative research and patient care. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it is recognized for its commitment to high-quality clinical research and the integration of scientific investigation with clinical practice. The institution specializes in various medical fields, including cardiology, oncology, and neurology, and collaborates with universities and research organizations to facilitate cutting-edge studies. With a focus on improving patient outcomes and contributing to public health, IRCCS Policlinico S. Donato plays a pivotal role in the development of new therapies and treatment protocols.

Locations

San Donato Milanese, Milan, Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials